$ZYME News

HC Wainwright & Co. Reiterates Buy on Zymeworks, Maintains $46 Price Target

Zymeworks: Royalty-Backed Biotech Flywheel With Underappreciated ADC Optionality

Zymeworks Announces $125M Buyback Plan

Zymeworks Inc. 2026 Q1 - Results - Earnings Call Presentation

Zymeworks Inc. (ZYME) Q1 2026 Earnings Call Transcript

Wells Fargo Maintains Overweight on Zymeworks, Raises Price Target to $34

Zymeworks (NASDAQ:ZYME) Misses Q1 Estimates But August PDUFA Date for Zanidatamab Offers Key Regulatory Catalyst

Zymeworks Q1 EPS $(0.59) Down From $(0.30) YoY, Sales $2.408M Down From $27.110M YoY

Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera

HC Wainwright & Co. Reiterates Buy on Zymeworks, Maintains $46 Price Target

Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026

Zymeworks Reveals New Phase 1 Data for ZW191, A Folate Receptor Alpha-Targeting ADC At AACR Annual Meeting 2026; ZW191 Demonstrates Anti-Tumor Activity In Heavily Pretreated Ovarian And Endometrial Cancers, Regardless Of FRα Expression; Confirmed Objective Response Rate Of 61% At Doses 6.4-9.6 Mg/kg In Platinum Resistant Ovarian Cancer

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

Zymeworks Presents Data On Six Poster Presentations Regarding New Preclinical Data From Its Antibody-Drug Conjugate, Payload Development Programs At American Association For Cancer Research Annual Meeting 2026

How Investors May Respond To Zymeworks (ZYME) Hiring EcoR1 Executives To Lead R&D And Deals

Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026

Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth

Zymeworks Appoints Kristin Stafford as Chief Financial Officer

Zymeworks Appoints Kristin Stafford As Chief Financial Officer Effective April 1 2026

How Investors May Respond To Zymeworks (ZYME) Fast Track Nod For Ovarian Cancer ADC ZW191